Quarterly report [Sections 13 or 15(d)]

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CHANGE IN EQUITY

v3.25.2
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CHANGE IN EQUITY - USD ($)
$ in Thousands
Common stock
Additional paid in capital
Accumulated other comprehensive (loss) income
Accumulated deficit
Total
Balance at the beginning of the period, shares at Dec. 31, 2023 1,363,008,102        
Balance at the beginning of the period at Dec. 31, 2023 $ 1,865 $ 1,064,569 $ (3,748) $ (1,023,173) $ 39,513
Increase (Decrease) in Stockholders' Equity          
Net loss       (48,503) (48,503)
Other comprehensive income (loss)     1,028   1,028
Issuance of shares upon exercise of stock options $ 8 66     74
Issuance of shares upon exercise of stock options (in shares) 6,297,720        
Issue of shares under At The Market sales agreement, net of commission and expenses $ 208 28,953     29,161
Issue of shares under At The Market sales agreement, net of commission and expenses (in shares) 163,669,056        
Share-based compensation expense   3,102     3,102
Balance at the end of the period at Mar. 31, 2024 $ 2,081 1,096,690 (2,720) (1,071,676) 24,375
Balance at the end of the period, shares at Mar. 31, 2024 1,532,974,878        
Balance at the beginning of the period, shares at Dec. 31, 2023 1,363,008,102        
Balance at the beginning of the period at Dec. 31, 2023 $ 1,865 1,064,569 (3,748) (1,023,173) 39,513
Increase (Decrease) in Stockholders' Equity          
Net loss         21,018
Balance at the end of the period at Jun. 30, 2024 $ 2,083 1,099,758 (3,412) (1,002,155) 96,274
Balance at the end of the period, shares at Jun. 30, 2024 1,534,220,604        
Balance at the beginning of the period, shares at Mar. 31, 2024 1,532,974,878        
Balance at the beginning of the period at Mar. 31, 2024 $ 2,081 1,096,690 (2,720) (1,071,676) 24,375
Increase (Decrease) in Stockholders' Equity          
Net loss       69,521 69,521
Other comprehensive income (loss)     (692)   (692)
Issuance of shares upon exercise of stock options $ 2       2
Issuance of shares upon exercise of stock options (in shares) 1,245,726        
Issue of shares under At The Market sales agreement, net of commission and expenses   10     10
Share-based compensation expense   3,058     3,058
Balance at the end of the period at Jun. 30, 2024 $ 2,083 1,099,758 (3,412) (1,002,155) $ 96,274
Balance at the end of the period, shares at Jun. 30, 2024 1,534,220,604        
Balance at the beginning of the period, shares at Dec. 31, 2024 1,535,653,620       1,535,653,620
Balance at the beginning of the period at Dec. 31, 2024 $ 2,085 1,105,653 (1,902) (1,093,987) $ 11,849
Increase (Decrease) in Stockholders' Equity          
Net loss       (47,584) (47,584)
Other comprehensive income (loss)     (2,510)   (2,510)
Issuance of shares upon exercise of stock options $ 9       9
Issuance of shares upon exercise of stock options (in shares) 7,738,026        
Issue of shares under At The Market sales agreement, net of commission and expenses $ 5 117     122
Issue of shares under At The Market sales agreement, net of commission and expenses (in shares) 3,702,162        
Share-based compensation expense   685     685
Balance at the end of the period at Mar. 31, 2025 $ 2,099 1,106,455 (4,412) (1,141,571) $ (37,429)
Balance at the end of the period, shares at Mar. 31, 2025 1,547,093,808        
Balance at the beginning of the period, shares at Dec. 31, 2024 1,535,653,620       1,535,653,620
Balance at the beginning of the period at Dec. 31, 2024 $ 2,085 1,105,653 (1,902) (1,093,987) $ 11,849
Increase (Decrease) in Stockholders' Equity          
Net loss         (77,924)
Balance at the end of the period at Jun. 30, 2025 $ 2,156 1,109,409 (10,612) (1,171,911) $ (70,958)
Balance at the end of the period, shares at Jun. 30, 2025 1,590,309,546       1,590,309,546
Balance at the beginning of the period, shares at Mar. 31, 2025 1,547,093,808        
Balance at the beginning of the period at Mar. 31, 2025 $ 2,099 1,106,455 (4,412) (1,141,571) $ (37,429)
Increase (Decrease) in Stockholders' Equity          
Net loss       (30,340) (30,340)
Other comprehensive income (loss)     (6,200)   (6,200)
Issuance of shares upon exercise of stock options $ 1       1
Issuance of shares upon exercise of stock options (in shares) 637,734        
Issue of shares under At The Market sales agreement, net of commission and expenses $ 56 1,597     1,653
Issue of shares under At The Market sales agreement, net of commission and expenses (in shares) 42,578,004        
Share-based compensation expense   1,357     1,357
Balance at the end of the period at Jun. 30, 2025 $ 2,156 $ 1,109,409 $ (10,612) $ (1,171,911) $ (70,958)
Balance at the end of the period, shares at Jun. 30, 2025 1,590,309,546       1,590,309,546